Intrinsic Value of S&P & Nasdaq Contact Us

4Front Ventures Corp. FFNTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
19/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

4Front Ventures Corp. (FFNTF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 18/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $97M, +25%/yr average growth. Net income is $92M (loss), growing at -33.1%/yr. Net profit margin is -94.1% (negative). Gross margin is 47.1% (-16.2 pp trend).

Balance sheet: total debt is $210M with negative equity of -$52M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.33 (tight liquidity). Debt-to-assets is 79.5%. Total assets: $264M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

FFNTF SharesGrow Score Overview

32/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.00001-0.0742
Volume50K
Avg Volume (30D)667.9K
Market Cap$62.3K
Beta (1Y)0.17
Share Statistics
EPS (TTM)-0.14
Shares Outstanding$649.69M
IPO Date2018-03-14
Employees374
CEOAndrew Fisher Thut
Financial Highlights & Ratios
Revenue (TTM)$97.44M
Gross Profit$45.89M
EBITDA$-18.26M
Net Income$-91.65M
Operating Income$-20.85M
Total Cash$3.4M
Total Debt$209.84M
Net Debt$206.44M
Total Assets$263.95M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINCA35086B2075

Price Chart

FFNTF
4Front Ventures Corp.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message